2,000 patient clinical trial using Novacyt’s nearpatient testing system initiated in London care homes

Paris, France and Camberley, UK – 22 July 2020 – Novacyt (EURONEXT GROWTH:
ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, notes the initiation
of a clinical trial by Queen Mary University of London using the Company’s innovative nearpatient
testing system. The study is investigating whether daily COVID-19 testing reduces
the infection rate, morbidity and mortality in the high-risk care home population.